DR. BART VANGENCK
ActiveDR. BART VANGENCK has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.01M and a net result of €367k. Equity is growing by ~2.6% per year across the filed fiscal years. Its solvency ranks better than 48% of 16132 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
98
/ 100
Excellent▼ -2 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability92▲+11
Solvency98▼-2
Growth78=
Stability100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200k at 30 days acceptable
Liquidity ample (current ratio 1.97 against 2.86 in 2024), and 38.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
61.7%
Return on assets
11.3%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
12 d late
2023
5 d early
2022
8 d late
2021
30 d late
2020
23 d early
2019
14 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
06-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€2.01M▼ 7.1%
2024 · €2.16M
2020: €1.95M
2021: €1.80M
2022: €1.95M
2023: €2.06M
2024: €2.16M
2020 → 2025
Total assets
€3.25M▲ 10.9%
2024 · €2.93M
2020: €2.19M
2021: €2.40M
2022: €2.73M
2023: €2.60M
2024: €2.93M
2020 → 2025
Net result
€367k▲ 5.2%
2024 · €349k
2020: €178k
2021: €205k
2022: €260k
2023: €219k
2024: €349k
2020 → 2025
Working capital
€1.20M▼ 16.2%
2024 · €1.44M
2020: €1.13M
2021: €1.00M
2022: €1.18M
2023: €1.32M
2024: €1.44M
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.80M-€1.95M▲ 8.2%€2.06M▲ 5.9%€2.16M▲ 4.7%€2.01M▼ 7.1%
Operating result€350k-€424k▲ 21.0%€411k▼ 2.9%€427k▲ 3.9%€507k▲ 18.6%
Net result€205k-€260k▲ 26.9%€219k▼ 15.9%€349k▲ 59.6%€367k▲ 5.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 19% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.25M
Fixed assets
€802k▲ 10.9%
Current assets
€2.45M▲ 10.9%
Equity and liabilities €3.25M
Equity
€2.01M▼ 7.1%
Debt
€1.25M▲ 61.5%
The debt ratio rises from 26.3% to 38.3%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€555k▲
2024 · €455k
Cash flow
€416k▲
2024 · €377k
Solvency
61.7%▼
2024 · 73.7%
Current ratio
1.97▼
2024 · 2.86
Quick ratio
1.97▼
2024 · 2.86
Debt / equity
0.62▲
2024 · 0.36
ROE
18.3%▲
2024 · 16.2%
ROA
11.3%▼
2024 · 11.9%
Interest coverage
8.32▲
2024 · 8.12
Debt
€1.25M▲
2024 · €773k
Debt ≤ 1 year
€1.25M▲
2024 · €773k
Income taxes
€163k▲
2024 · €140k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Total assets
20/58€2.93M€3.25M▲
Fixed assets
21/28€723k€802k▲
Tangible fixed assets
22/27€723k€802k▲
Current assets
29/58€2.21M€2.45M▲
Amounts receivable within one year
40/41€173k€253k▲
Investments
50/53€1.40M€1.81M▲
Cash & bank
54/58€635k€386k▼
Total equity & liabilities
10/49€2.93M€3.25M▲
Equity
10/15€2.16M€2.01M▼
Contributions / capital
10/11€12k€12k=
Reserves
13€2.15M€1.99M▼
Accumulated profits (losses)
14€0€0=
Amounts payable
17/49€773k€1.25M▲
Amounts payable within one year
42/48€773k€1.25M▲
Trade debts payable within one year
44€295€14k▲
Income statement
Code20242025
Gross operating margin
9900€461k€563k▲
Operating result
9901€427k€507k▲
Financial income
75€118k€90k▼
Financial charges
65€56k€67k▲
Result before taxes
9903€490k€530k▲
Income taxes
67/77€140k€163k▲
Net result for the period
9904€349k€367k▲
Result to be appropriated
9905€349k€367k▲
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €367k ▲5.2%
Operating result €507k, net result €367k, both a record.
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 12 days late
2024
26-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €2MEq €2.06M ▲5.9%
4 profitable years in a row build equity to €2.06M.
08-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 8 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
08-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
17-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
08-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
20-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
04-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Comparable companies · same sector, comparable size
Similar companies · same sector, comparable size
Experconsult
BE 0454.735.010
Brussel · Eq €2.00M
DOKTERSPRAKTIJK HERWIG VAN AERDE
BE 0477.582.963
Genk · Eq €2.00M
Société Médicale Dr MAHFOUDHI
BE 0823.410.828
Liège · Eq €1.99M
Service de Promotion de la Santé à l'Ecole Hainaut Picardie
BE 0410.783.221
Tournai · Eq €1.99M
CONTROLE MEDICAL SECUREX - MEDISCHE CONTROLE SECUREX
BE 0462.522.922
Etterbeek · Eq €2.03M
Of 9,097 companies in sector 86210 we hold annual accounts for 6,318. 2,921 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded10-09-2008
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 21-08-2026. Scores and ratios are computed by Checked and are not a credit decision.